TASI 8150 · Insurance · ACIG
Statement of Changes in Equity
9M / Q3 2023Equity movements
| Movement | Total equitySAR thousands |
|---|---|
| 2023 equity movements | |
| Balance at 1 January 2023 as previously reported | 162,311 |
| Transition adjustment on initial application of IFRS 17 | (11,094) |
| Transition adjustment on initial application of IFRS 9 | 37,730 |
| Restated balance at 1 January 2023 | 188,947 |
| Sale of FVOCI investments | - |
| Net income attributable to shareholders | 46,362 |
| Total comprehensive income for the period | 46,362 |
| Balance at 2023-09-30 | 235,309 |
| 2022 equity movements | |
| Balance at 1 January 2022 as previously reported | 32,036 |
| Transition adjustment on initial application of IFRS 17 | (6,856) |
| Transition adjustment on initial application of IFRS 9 | 34,830 |
| Restated balance at 1 January 2022 | 60,010 |
| Change in fair value reserve on FVOCI investments | 2,003 |
| Net loss attributable to shareholders | (27,193) |
| Total comprehensive income (loss) for the period | (25,190) |
| Increase in share capital through rights issue | 150,000 |
| Balance at 2022-09-30 | 184,820 |